ArticleEuropean journal of medical research2025
NF-κB-mediated enhancement of H3K27me3 through EZH2: a mechanism to suppress pyocyanin-induced autophagy in macrophages.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis.Cell death & disease · 2026Article
- Macrophage reprogramming and functional plasticity in sepsis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHistone modification is a key mechanism of epigenetic regulation. Our previous study demonstrated that histone H3 acetylation at lysine 27 (H3K27ac) promotes pyocyanin (PYO)-induced autophagy in macrophages. However, the regulatory role of H3K27 trimethylation (H3K27me3) in this process remains unclear.
methodsTHP-1 macrophages were treated with PYO, and autophagy was assessed by evaluating LC3B II expression and autophagosome formation. The expression of EZH2 and JMJD3 was analyzed to identify the key enzyme responsible for regulating H3K27me3. Nuclear-cytoplasmic fractionation and co-immunoprecipitation were performed to determine the distribution of NF-κB and its interaction with H3K27me3. To explore the role of H3K27me3 in PYO-induced autophagy, cells were co-treated with PYO and EZH2 inhibitors (EI1 or CPI-169), and the transcription of ULK1, BECN1, and MAP1LC3B was analyzed using ChIP-qPCR. Similarly, to assess the role of NF-κB, cells were co-treated with PYO and the NF-κB nuclear translocation inhibitor curcumin, followed by ChIP-qPCR analysis. Finally, the reciprocal transcriptional regulation between NF-κB and H3K27me3 was further investigated.
resultsPYO increases LC3B II expression and autophagosome formation in THP-1 macrophages. It also elevates H3K27me3 levels by upregulating EZH2 expression, while JMJD3 remains unchanged. Co-treatment with EZH2 inhibitors reduces H3K27me3 levels, leading to increased LC3B II expression and enhanced autophagosome formation. ChIP-qPCR analysis shows that H3K27me3 enrichment at the ULK1 and MAP1LC3B promoters correlates with reduced transcription, whereas BECN1 remains unaffected. PYO promotes nuclear translocation of NF-κB and enhances its interaction with H3K27me3. ChIP-qPCR further reveals that NF-κB represses the transcription of ULK1 and MAP1LC3B and upregulates EZH2 transcription, which contributes to increased H3K27me3 levels and further suppression of autophagy-related gene expression.
conclusionsThe NF-κB/EZH2/H3K27me3 axis plays a pivotal role in suppressing PYO-induced autophagy in macrophages by repressing the transcription of ULK1 and MAP1LC3B.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.